If you receive and transmit electronic prescriptions, you’re probably aware that they conform to a standard set by the National Council for Prescription Drug Programs (NCPDP).
South Carolina DHEC now requires all long-term care (LTC) pharmacies to report dispensed controlled substances to the state’s Prescription Monitoring Program (SC PMP). The department wants compliance by the end of the month, and it is in the process of notifying pharmacies.
Effective January 4, 2019, the Michigan Automated Prescription System (MAPS) for the reporting of controlled substances made gabapentin a Schedule V controlled substance. Pharmacies have 7 days to comply, which is Friday, January 11.
Effective January 1, 2019, the Tennessee Prescription Monitoring Program (TN PMP) requires reporting of the Treatment Type and ICD-10 Diagnosis Code.
Once again, QS/1 is leading the way to help you make the transition from the current version of the National Council for Prescription Drug Programs (NCPDP) SCRIPT standard to the new one as smooth as possible. Pharmacies and prescribers that transmit electronic prescriptions have a little more than a year to convert to the new version. Currently, pharmacies and prescribers that wish to prescribe electronically must transmit those e-prescriptions using the SCRIPT Standard version 10.6. On January 1, 2020, transmissions must be made using the New SCRIPT Standard version 2017071.
Pharmacy Benefit Manager (PBM) audits continue to plague pharmacies. There are more desk audits than ever before and plans are finding new ways to recoup payment on prescriptions.
Medicare is a beneficial program for Americans who are over age 65 or have certain disabilities, but providers sometimes find compliance issues a challenge. An understanding of mandates and how to properly submit claims will ensure organizations are reimbursed for Medicare Part B-covered medications, equipment and supplies, such as nebulizer-inhalation medications, oral immunosuppressive drugs and diabetic testing supplies. Occasionally, providers may unknowingly submit noncompliant or even fraudulent claims for the products and services they offer.
On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. This is the first major federal addiction legislative package in decades and is designed to tackle the opioid epidemic through a six-part initiative: prevention, treatment, recovery, law enforcement, criminal justice reform and overdose reversal.